In several kinds of cancer, malignant cells display an excess of a specific type of surface receptor, which when stimulated causes unchecked growth of such cells (SN: 9/11/04, p. 164: Available to subscribers at An Exploitable Mutation: Defect might make some lung cancers treatable).
Scientists now report that a novel agent bottles up this so-called epidermal growth factor receptor and stalls the growth of cancer cells in a lab dish.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.